324 research outputs found

    Wearable RealTime Heart Attack Detection and Warning System to Reduce Car Accidents in Qatar

    Get PDF
    Introduction Fatal car accidents have become an alarming issue all over the globe. A sudden medical condition such as a heart attack causes medical symptoms that lead a driver to lose consciousness while driving and consequently leads to a crash. Many studies have demonstrated the high correlation between the driver's sudden medical conditions and involving in a car crash [1][2]. Therefore, to reduce car crashes from the driver's sudden illness from heart-attack as well as save the driver's life in a timely manner, in this work, we discuss the development of a portable wearable system that can continuously monitor the driver for any early symptoms of heart attack and inform him before losing conciuous to stop the car as well as inform medical caregivers to save life. Background Myocardial infarction (MI) is the medical term for the medical condition commonly known as a heart attack, a serious medical emergency in which the blood supply to the heart is suddenly blocked, usually by a blood clot, leading to damage heart muscle [3]. A complete blockage of a coronary artery is a 'STEMI' heart attack (ST-elevation MI), whereas a partial blockage would be a 'NSTEMI' heart attack (a non-ST-elevationMI) [4]. The average, resting heart rhythm has a QRS-complex following a P-wave and followed by a T-wave, as illustrated in Figure 1(a). A STEMI heart attack will cause an elevation in the ST-complex (Figure 1(b)), whereas a NSTEMI heart attack would not signify ST elevation, but nonetheless can cause ST-segment depression or T-wave inversion (Figure 1(c)), which can be detected immediately by a real-time device to save the driver's life. Method The prototype system consists of two subsystems (Figure 2) that communicate wirelessly using Bluetooth low energy (BLE) technology: wearable sensor subsystem, and an intelligent heart attack detection and warning subsystem. Wearable Subsystem: The wearable chest-belt sub-system includes dry electrodes (reference and two electrodes for differential acquisition), analogue front end (AFE), power management module, and RFDuino microcontroller with BLE. This subsystem acquires the ECG signals from human body continuously and sends these raw measurements wirelessly using BLE technology to the intelligent subsystem. Reusable and smaller dimension dry electrodes (Cognionics, Inc) were embedded in a chest belt to be worn by a car driver. AD82832 AFE is an integrated signal conditioning block to extract, amplify (60 dB gain), and filter (0.48-41 Hz) ECG signal in the presence of noisy conditions. Lithium Polymer (LiPo) battery of 3.7 V (1000 mAH) with the Microchip MCP73831 charge controllers, and Texas instruments' TPS61200 voltage regulators to supply 3 V to the wearable system. The miniaturized ARM Cortex M0 RFDuino microcontroller digitizes the signal at 500 Hz sampling rate and transmits the acquired signal through built-in BLE to decision making subsystem. Intelligent Decision-making Subsystem: This subsystem will receive the ECG signals from the wearable subsystem continuously. It is capable of processing, analyzing the received ECG signals, and making the right decision using support vector machine (SVM) algorithm to classify the normal and abnormal ECG signal to detect heart attack symptoms. This subsystem was built around the single board computer, Raspberry Pi 3 (RPi3) along with SIM 908 GSM and GPS module for location information and alerting service. Multi-threaded python code was written for RPi3 to automatically acquire, buffer, baseline correction and digital smoothing and analyse the ECG data. SVM algorithm was implemented in RPi 3 and used for real-time abnormality detection using the trained model and classification was done using LIBSVM, an open source library [5]. 4-fold cross-validation was used to evaluate classification accuracy. SIM908 GSM+GPS shield attached on the RPi3 to provide car location (latitude, longitude) and to connect to the mobile network for generating an automatic call to medical emergency. This subsystem is designed to take power from the car battery using Cigarette Lighter Socket, which powers the system only when the car's engine is ON. To develop the intelligent program for decision-making subsystem, public MIT-BIH ST change database [6] was used to train a SVM model for normal, ST-elevated, and T-inverted ECG-beats with the time domain (TD), frequency domain (FD) and extended time-frequency domain (TFD) features extracted. The TD features mean, variance, skewness, kurtosis, and coefficient of variation and the FD features spectral flux, spectral entropy and spectral flatness were calculated to spot abnormalities in the ECG-beats. Three time-frequency (TF) distributions were also used in this study: Wigner-Ville Distribution (WVD), Spectrogram (SPEC), and Extended Modified B-Distribution (EMBD). Result and Discussion Recorded ECG Traces: It was clearly revealed from Fig. 5 that the ECG signal transmitted using the prototyped system is in clinical grade. Training SVM: Five hundred traces from each patient and total 2500 traces from MIT-BIH database having either normal or abnormal heart rhythm were segmented and averaged for each case (Figure 6 (A, B, & C)). The power spectral of the signal in Figure 6 (D, E & F) shows that the power spectral density peaks appear at different frequencies for normal and abnormal ECG signals. This reflects that the FD feature can help in classifying the ECG signals. However, TD, FD, and TFD features provide an insight on the signal while compensating for the noise or motion artefacts. Classification using SVM: Table 1 below summarizes the accuracy of the prototyped device. EMBD produces higher accuracy in classification of ECG signal. Conclusion This work shows the possibility to detect driver's heart attack reliably using the developed prototype system. SVM machine learning algorithm that was trained with a sufficiently high number of training data can classify STEMI or NSTEMI with approximately 97.4% and 96.3% accuracy respectively when the extended TF features (with EMBD distribution) were used for training and classification. The maximum current drawn by the wearable chest-belt subsystem during continuous acquisition is 9.3 mA, which ensures the life span of a 1000 mAh LiPo battery is 75 hours, once it is fully charged and therefore it can be expected that the device can run longer without requiring recharging daily.qscienc

    The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review

    Get PDF
    Warfarin has been utilized for decades as an effective anticoagulant in patients with a history of strong risk factors for venous thromboembolism (VTE). Established adverse effects include bleeding, skin necrosis, teratogenicity during pregnancy, cholesterol embolization, and nephropathy. One of the lesser-known long-term side effects of warfarin is an increase in systemic arterial calcification. This is significant due to the association between vascular calcification and cardiovascular morbidity and mortality. Direct oral anticoagulants (DOACs) have gained prominence in recent years, as they require less frequent monitoring and have a superior side effect profile to warfarin, specifically in relation to major bleeding. The cost and lack of data for DOACs in some disease processes have precluded universal use. Within the last four years, retrospective cohort studies, observational studies, and randomized trials have shown, through different imaging modalities, that multiple DOACs are associated with slower progression of vascular calcification than warfarin. This review highlights the pathophysiology and mechanisms behind vascular calcification due to warfarin and compares the effect of warfarin and DOACs on systemic vasculature

    The pathophysiology of fluid and electrolyte balance in the older adult surgical patient

    Get PDF
    Background & aims: Age-related physiological changes predispose even the healthy older adult to fluid and electrolyte abnormalities which can cause morbidity and mortality. The aim of this narrative review is to highlight key aspects of age-related pathophysiological changes that affect fluid and electrolyte balance in older adults and underpin their importance in the perioperative period. Methods: The Web of Science, MEDLINE, PubMed and Google Scholar databases were searched using key terms for relevant studies published in English on fluid balance in older adults during the 15 years preceding June 2013. Randomised controlled trials and large cohort studies were sought; other studieswere used when these were not available. The bibliographies of extracted papers were also searched for relevant articles. Results: Older adults are susceptible to dehydration and electrolyte abnormalities, with causes ranging from physical disability restricting access to fluid intake to iatrogenic causes including polypharmacy and unmonitored diuretic usage. Renal senescence, as well as physical and mental decline, increase this susceptibility. Older adults are also predisposed to water retention and related electrolyte abnormalities, exacerbated at times of physiological stress. Positive fluid balance has been shown to be an independent risk factor for morbidity and mortality in critically ill patients with acute kidney injury. Conclusions: Age-related pathophysiological changes in the handling of fluid and electrolytes make older adults undergoing surgery a high-risk group and an understanding of these changes will enable better management of fluid and electrolyte therapy in the older adult

    Supplemental Vitamins and Minerals for CVD Prevention and Treatment

    Get PDF
    The authors identified individual randomized controlled trials from previous meta-analyses and additional searches, and then performed meta-analyses on cardiovascular disease outcomes and all-cause mortality. The authors assessed publications from 2012, both before and including the U.S. Preventive Service Task Force review. Their systematic reviews and meta-analyses showed generally moderate- or low-quality evidence for preventive benefits (folic acid for total cardiovascular disease, folic acid and B-vitamins for stroke), no effect (multivitamins, vitamins C, D, β-carotene, calcium, and selenium), or increased risk (antioxidant mixtures and niacin [with a statin] for all-cause mortality). Conclusive evidence for the benefit of any supplement across all dietary backgrounds (including deficiency and sufficiency) was not demonstrated; therefore, any benefits seen must be balanced against possible risks

    Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome

    Get PDF
    Introduction: Intravenous (IV) fluids may be associated with complications not often attributed to fluid type. Fluids with high chloride concentrations such as 0.9 % saline have been associated with adverse outcomes in surgery and critical care. Understanding the association between fluid type and outcomes in general hospitalized patients may inform selection of fluid type in clinical practice. We sought to determine if the type of IV fluid administered to patients with systemic inflammatory response syndrome (SIRS) is associated with outcome. Methods: This was a propensity-matched cohort study in hospitalized patients receiving at least 500 mL IV crystalloid within 48 hours of SIRS. Patient data was extracted from a large multi-hospital electronic health record database between January 1, 2009, and March 31, 2013. The primary outcome was in-hospital mortality. Secondary outcomes included length of stay, readmission, and complications measured by ICD-9 coding and clinical definitions. Outcomes were adjusted for illness severity using the Acute Physiology Score. Of the 91,069 patients meeting inclusion criteria, 89,363 (98 %) received 0.9 % saline whereas 1706 (2 %) received a calcium-free balanced solution as the primary fluid. Results: There were 3116 well-matched patients, 1558 in each cohort. In comparison with the calcium-free balanced cohort, the saline cohort experienced greater in-hospital mortality (3.27 % vs. 1.03 %, P <0.001), length of stay (4.87 vs. 4.38 days, P = 0.016), frequency of readmission at 60 (13.54 vs. 10.91, P = 0.025) and 90 days (16.56 vs. 12.58, P = 0.002) and frequency of cardiac, infectious, and coagulopathy complications (all P <0.002). Outcomes were defined by administrative coding and clinically were internally consistent. Patients in the saline cohort received more chloride and had electrolyte abnormalities requiring replacement more frequently (P <0.001). No differences were found in acute renal failure. Conclusions: In this large electronic health record, the predominant use of 0.9 % saline in patients with SIRS was associated with significantly greater morbidity and mortality compared with predominant use of balanced fluids. The signal is consistent with that reported previously in perioperative and critical care patients. Given the large population of hospitalized patients receiving IV fluids, these differences may confer treatment implications and warrant corroboration via large clinical trials. Trial registration: NCT02083198 clinicaltrials.gov; March 5, 201

    Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

    Get PDF
    BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

    Federated Benchmarking of Medical Artificial Intelligence With MedPerf

    Get PDF
    Medical artificial intelligence (AI) has tremendous potential to advance healthcare by supporting and contributing to the evidence-based practice of medicine, personalizing patient treatment, reducing costs, and improving both healthcare provider and patient experience. Unlocking this potential requires systematic, quantitative evaluation of the performance of medical AI models on large-scale, heterogeneous data capturing diverse patient populations. Here, to meet this need, we introduce MedPerf, an open platform for benchmarking AI models in the medical domain. MedPerf focuses on enabling federated evaluation of AI models, by securely distributing them to different facilities, such as healthcare organizations. This process of bringing the model to the data empowers each facility to assess and verify the performance of AI models in an efficient and human-supervised process, while prioritizing privacy. We describe the current challenges healthcare and AI communities face, the need for an open platform, the design philosophy of MedPerf, its current implementation status and real-world deployment, our roadmap and, importantly, the use of MedPerf with multiple international institutions within cloud-based technology and on-premises scenarios. Finally, we welcome new contributions by researchers and organizations to further strengthen MedPerf as an open benchmarking platform

    Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: A united approach

    Get PDF
    Item does not contain fulltextCerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy. SVD can present as a stroke or cognitive decline, or can have few or no symptoms. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive deficits, physical disabilities, and other symptoms of neurodegeneration. Terminology and definitions for imaging the features of SVD vary widely, which is also true for protocols for image acquisition and image analysis. This lack of consistency hampers progress in identifying the contribution of SVD to the pathophysiology and clinical features of common neurodegenerative diseases. We are an international working group from the Centres of Excellence in Neurodegeneration. We completed a structured process to develop definitions and imaging standards for markers and consequences of SVD. We aimed to achieve the following: first, to provide a common advisory about terms and definitions for features visible on MRI; second, to suggest minimum standards for image acquisition and analysis; third, to agree on standards for scientific reporting of changes related to SVD on neuroimaging; and fourth, to review emerging imaging methods for detection and quantification of preclinical manifestations of SVD. Our findings and recommendations apply to research studies, and can be used in the clinical setting to standardise image interpretation, acquisition, and reporting. This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE)

    Pediatric trauma and emergency surgery: an international cross-sectional survey among WSES members

    Get PDF
    Background: In contrast to adults, the situation for pediatric trauma care from an international point of view and the global management of severely injured children remain rather unclear. The current study investigates structural management of pediatric trauma in centers of different trauma levels as well as experiences with pediatric trauma management around the world. Methods: A web-survey had been distributed to the global mailing list of the World Society of Emergency Surgery from 10/2021-03/2022, investigating characteristics of respondents and affiliated hospitals, case-load of pediatric trauma patients, capacities and infrastructure for critical care in children, trauma team composition, clinical work-up and individual experiences with pediatric trauma management in response to patients´ age. The collaboration group was subdivided regarding sizes of affiliated hospitals to allow comparisons concerning hospital volumes. Comparable results were conducted to statistical analysis. Results: A total of 133 participants from 34 countries, i.e. 5 continents responded to the survey. They were most commonly affiliated with larger hospitals (&gt; 500 beds in 72.9%) and with level I or II trauma centers (82.0%), respectively. 74.4% of hospitals offer unrestricted pediatric medical care, but only 63.2% and 42.9% of the participants had sufficient experiences with trauma care in children ≤ 10 and ≤ 5&nbsp;years of age (p = 0.0014). This situation is aggravated in participants from smaller hospitals (p &lt; 0.01). With regard to hospital size (≤ 500 versus &gt; 500 in-hospital beds), larger hospitals were more likely affiliated with advanced trauma centers, more elaborated pediatric intensive care infrastructure (p &lt; 0.0001), treated children at all ages more frequently (p = 0.0938) and have higher case-loads of severely injured children &lt; 12&nbsp;years of age (p = 0.0009). Therefore, the majority of larger hospitals reserve either pediatric surgery departments or board-certified pediatric surgeons (p &lt; 0.0001) and in-hospital trauma management is conducted more multi-disciplinarily. However, the majority of respondents does not feel prepared for treatment of severe pediatric trauma and call for special educational and practical training courses (overall: 80.2% and 64.3%, respectively). Conclusions: Multi-professional management of pediatric trauma and individual experiences with severely injured children depend on volumes, level of trauma centers and infrastructure of the hospital. However, respondents from hospitals at all levels of trauma care complain about an alarming lack of knowledge on pediatric trauma management

    Textbook outcome in urgent early cholecystectomy for acute calculous cholecystitis: results post hoc of the S.P.Ri.M.A.C.C study

    Get PDF
    Introduction: A textbook outcome patient is one in which the operative course passes uneventful, without complications, readmission or mortality. There is a lack of publications in terms of TO on acute cholecystitis. Objetive: The objective of this study is to analyze the achievement of TO in patients with urgent early cholecystectomy (UEC) for Acute Cholecystitis. and to identify which factors are related to achieving TO. Materials and methods: This is a post hoc study of the SPRiMACC study. It ́s a prospective multicenter observational study run by WSES. The criteria to define TO in urgent early cholecystectomy (TOUEC) were no 30-day mortality, no 30-day postoperative complications, no readmission within 30&nbsp;days, and hospital stay ≤ 7&nbsp;days (75th percentile), and full laparoscopic surgery. Patients who met all these conditions were taken as presenting a TOUEC. Outcomes: 1246 urgent early cholecystectomies for ACC were included. In all, 789 patients (63.3%) achieved all TOUEC parameters, while 457 (36.6%) failed to achieve one or more parameters and were considered non-TOUEC. The patients who achieved TOUEC were younger had significantly lower scores on all the risk scales analyzed. In the serological tests, TOUEC patients had lower values for in a lot of variables than non-TOUEC patients. The TOUEC group had lower rates of complicated cholecystitis. Considering operative time, a shorter duration was also associated with a higher probability of reaching TOUEC. Conclusion: Knowledge of the factors that influence the TOUEC can allow us to improve our results in terms of textbook outcome
    corecore